BioTheranostics Breaking News NCCN Adds Mirati Therapeutics' Krazati to Guidelines for KRAS-Mutant NSCLC With Brain Metastases European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer Genialis Closes $13M Series A Funding Round Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers
